Skip to main content
Signal8

BUTHMAN MARK A

SEC insider (Form 3/4/5 filer). CIK 0001223783. Director at IDEX CORP /DE/ (IEX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on May 6, 2026. Located in EXTON, PA.

Companies BUTHMAN MARK A has filed insider reports for

  • IDEX CORP /DE/ (IEX): Director
  • WEST PHARMACEUTICAL SERVICES INC (WST): Director
BUTHMAN MARK A profile photo

BUTHMAN MARK A

CIK: 0001223783

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

IDEX CORP /DE/ logo
IEX

IDEX CORP /DE/

Director
WEST PHARMACEUTICAL SERVICES INC logo
WST

WEST PHARMACEUTICAL SERVICES INC

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • IDEX CORP /DE/ logo
    IEX

    IDEX CORP /DE/

    May 6, 2026
    Award
    Direct
    805 shares-
  • WEST PHARMACEUTICAL SERVICES INC logo
    WST

    WEST PHARMACEUTICAL SERVICES INC

    May 4, 2026
    Award
    Direct
    791 shares-
  • IDEX CORP /DE/ logo
    IEX

    IDEX CORP /DE/

    May 8, 2025
    Award
    Direct
    895 shares-
  • WEST PHARMACEUTICAL SERVICES INC logo
    WST

    WEST PHARMACEUTICAL SERVICES INC

    May 6, 2025
    Award
    Direct
    1.1K shares-

1-4 of 4